AAM’s Francer On Tackling Tactics That Hurt Market Access For Gx, Biosimilars

 
• By Anju Ghangurde
  
Francer_Jeff
Jeff Francer, Interim CEO and General Counsel, Association for Accessible Medicines
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip